Funding profile · Post-acute care services
Call9
$34 million of equity and a $6 million debt facility went into a nursing home emergency medicine company that wound down in June 2019. No Form D was ever filed under its name. The clearest numbers on the way down come from its lender, which had to publish them.
Data as of September 23, 2026. Company-reported figures are labeled.
Rounds at a glance
| When | Round | Amount | Investors | Source |
|---|---|---|---|---|
| Spring 2015 | Y Combinator | Not disclosed | Y Combinator | Reported |
| Jan 2016 | Series A | $10.0M | Led by Index Ventures, Neil Rimer to the board; Ali Rowghani of the YC Continuity Fund, Joe Lonsdale, Anne Wojcicki | Reported |
| 2017 | Series B | $24.0M | Redmile Group, which later held more than 50 percent | Reported |
| 2017 to 2019 | Venture debt | $6.0M committed; $2.59M principal at peak | Western Technology Investment, through Venture Lending & Leasing VIII, Inc. | SEC filings |
| 2019 | Series C | Never closed | None | Reported |
| 2015 to 2019 | Named backers across all rounds | $34M equity | Index Ventures, Redmile Group, Refactor Capital, Y Combinator and its Continuity Fund, Moment Ventures, Anne Wojcicki, Sam Altman, Ashton Kutcher, Joe Lonsdale | Reported |
What the filings show
Venture Lending & Leasing VIII, Inc. · Form 10-K · filed Mar 14, 2019
- As of
- December 31, 2018
- Position
- Five Call9, Inc. senior secured loans, Other Healthcare
- Principal
- $2,591,022
- Cost
- $2,482,817
- Fair value
- $2,482,817 · carried at full cost
- Terms
- 9.0% interest, 3.6% to 3.7% end of term payment, maturities Jan 1 to Mar 1, 2021
- Commitment
- $6,000,000 unfunded commitment as of Dec 31, 2017, expiring Jun 30, 2018
- Filing
- SEC EDGAR, CIK 0001642862
Venture Lending & Leasing VIII, Inc. · Form 10-Q · filed Nov 13, 2019
- As of
- September 30, 2019
- Position
- One consolidated Call9, Inc. senior secured loan, non-accrual
- Principal
- $2,150,765
- Cost
- $1,968,596
- Fair value
- $498,510
- Terms
- 18.0% interest, no maturity date shown
- Footnote
- “These loans have been accelerated from their original maturity and are due in their entirety.”
- Filing
- SEC EDGAR, CIK 0001642862
Reading the filings
- Thirty-four million dollars moved with no Form D on file.EDGAR company and full text searches return no Form D for Call9. Companies raising under Section 4(a)(2) rather than Regulation D file none, so this is not a violation. It does mean the equity history here is reconstructed from press reports, not filings.
- The only SEC paper trail is the lender’s, and it is quarterly.Western Technology Investment lent through Venture Lending & Leasing VIII, a registered fund that must publish a schedule of investments. That turns a private collapse into a public series of fair values: $844,331 at December 31, 2017, $2,482,817 at December 31, 2018, $2,242,110 at March 31, 2019, $1,252,246 at June 30, $498,510 at September 30, then nothing.
- The loan lost three quarters of its value in six months.At March 31, 2019 the loans were carried at 100 percent of cost. At June 30 fair value was $1,252,246 against $2,048,596 of cost, about 61 cents on the dollar. At September 30 it was $498,510 against $1,968,596, about 25 cents. Against $2,150,765 of principal, the September mark is about 23 cents.
- The rate tells you when the default happened.Through March 31, 2019 the loans carry 9.0 percent. At June 30 a single consolidated loan carries 18.0 percent and is flagged non-accrual, the fund’s classification for a borrower that in management’s opinion “either ceases or drastically curtails its operation.” That is the quarter Peck describes, when cash fell below what was owed and WTI took a lien.
- Less than half the debt facility was ever drawn.The December 31, 2017 commitment schedule shows $6,000,000 available. Peak principal a year later was $2,591,022, about 43 percent of it. A company burning a $24 million Series B did not, or could not, pull the rest.
- A senior lender at a quarter of cost means the equity was worth zero.$34 million of preferred and common sat behind a loan marked at 23 cents on the principal. The fund’s third quarter 2019 discussion attributes a jump in realized losses to “a significant non-accrual loan write off.” By December 31, 2019, Call9 is gone from the schedule.
- Control, not the cash balance, is what the reporting blames.Crain’s reported that Redmile Group held more than 50 percent and pushed toward fee-for-service billing, away from the shared savings contracts the model was built on. No filing confirms the split; it rests on sourced reporting and Peck’s own account.
Commercial signals
| Signal | Detail | Source type |
|---|---|---|
| Customers | Twelve New York nursing homes at the end. Named partners included Central Island Healthcare, Centers Health Care, CareRite and ArchCare. | Independent |
| Payers | Anthem, Blue Cross Blue Shield, Healthfirst and Medicare Advantage plans. Seven commercial payers as of September 2018. | Independent |
| Medicare | No Part B pathway. More than 3,500 Part B patients treated at a loss, stated in House testimony in September 2018. | Public record |
| Headcount | About 200 at peak, about 100 laid off at the wind-down. | Independent |
| Regulatory assets | No FDA record, no registered trial, no federal grant found. Nothing to sell but software and a brand. | Not found |
| Corporate status | CALL9, INC. and CALL9 MEDICAL, P.C. are both Inactive in New York State records. | Public record |
What to watch
- Whether the Call9 Medical restart announced in July 2019 ever produced a filing. The New York entity is Inactive.
- Curve Health, founded by Peck in 2020, which holds Call9’s intellectual property and branding rights and raised a $6 million seed round led by Lightspeed Venture Partners.
- Whether a RUSH Act style contracting authority is ever enacted. Three attempts across three Congresses ended at committee referrals.
- Any recovery on the written off loan in later fund filings.
The Call9 story on Healthcare DiscoveryHealthcare Discovery
Related companies
Sources
- Public recordVenture Lending & Leasing VIII, Inc., Forms 10-K and 10-Q, schedules of investments
- Public recordEDGAR company and full text search for Call9, no Form D found
- Public recordEntity records for CALL9, INC. and CALL9 MEDICAL, P.C.
- Public recordTestimony of Timothy C. Peck, MD, Subcommittee on Health
- Public recordH.R. 6502, S. 3447, S. 2576 and H.R. 4890, RUSH Act bill status
- IndependentAfter shutdown, Call9 founder plans a comeback
- IndependentCall9 is shutting down operations
- IndependentOnce Backed with $34M, Call9 to Shut Down
- IndependentCall9 Raises $10 Million Series A Led by Index Ventures
- IndependentThe founder of shuttered Call9 started a new venture
Compiled from SEC, New York State, CMS and congressional public records and published reports as of September 23, 2026. Form D notices report offerings under Regulation D; no Form D was located for this company. Healthcare Venture Capital Fund holds no position in Call9. This page is not an offer to sell or a recommendation to buy any security.
